Concepedia

Author

Erlong Zhang

Army Medical UniversityORCID

Also Known As

E Zhang, Enqi Zhang, Enyuan Zhang, Er-Long Zhang, Erfeng Zhang, Erfu Zhang, Erlong Zhang, Eryuan Zhang, Er‐Long Zhang, Jianhua Cui

65

Publications

2.6K

Citations

17

H-Index

52

Concepts

All Affiliations

Army Medical UniversityBeijing National Laboratory for Molecular SciencesChinese Academy of SciencesAnhui Normal UniversitySouthwest Hospital
EZ

About

Erlong Zhang is an author at Army Medical University specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

520

2

Biochemistry

4

4

195

3

Engineering

3

3

361

4

Health Sciences

2

2

145

5

Natural Sciences

1

1

36

Erlong Zhang

×

20

Publications

885

Citations

16

H-Index

YearCitations

Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent

Erlong Zhang, Shenglin Luo, Xu Tan,

Biomaterials

2013

219

Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells

Yang Wang, Tao Liu, Erlong Zhang,

Biomaterials

2014

128

A multifunctional heptamethine near-infrared dye for cancer theranosis

Shenglin Luo, Xu Tan, Qingrong Qi,

Biomaterials

2012

94

Metabolite Modulation in Human Plasma in the Early Phase of Acclimatization to Hypobaric Hypoxia

Wenting Liao, Bao Liu, Jian Chen,

Scientific Reports

2016

60

Luminescent cyclometallated platinum(<scp>ii</scp>) complexes: highly promising EGFR/DNA probes and dual-targeting anticancer agents

Yang Zhang, Qun Luo, Wei Zheng,

Inorganic Chemistry Frontiers

2017

48

Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells

Jun Du, Erlong Zhang, Yao Zhao,

Metallomics

2015

36

Dual-targeting organometallic ruthenium(<scp>ii</scp>) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands

Yang Zhang, Wei Zheng, Qun Luo,

Dalton Transactions

2015

35

A Signature of Circulating microRNAs Predicts the Susceptibility of Acute Mountain Sickness

Bao Liu, He Huang, Gang Wu,

Frontiers in Physiology

2017

33

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma

Yixing Gao, Bao Liu, Lan Feng,

Frontiers in Oncology

2019

32

Human positive coactivator 4 is a potential novel therapeutic target in non-small cell lung cancer

Yizhi Peng, Jing Yang, Erlong Zhang,

Cancer Gene Therapy

2012

28

Page 1